← SynDRA
I-BRD9
SynDRA canonical compound SYN0058657 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | BRD9 |
| Mechanism of action | bromodomain inhibitor |
All known targets
Mechanisms of action (all sources)
- BRD9 BINDER
- BET bromodomain inhibitor
- BRD9 INHIBITOR
Cross-references
Synonyms
- CS-5587
- GSK602
- I-BRD9 (GSK602)
- compound 45 [PMID 25856009]
- compound 45 (PMID 25856009)
- RefChem:147541
- MFCD28952791
- H1B
- I-BRD9?
- GTPL8397
- orb1300400
- SCHEMBL21259435
- SCHEMBL21752089
- SCHEMBL21752090
- C22H22F3N3O3S2
- WRUWGLUCNBMGPS-UHFFFAOYSA-N
- GLXC-06370
- EX-A1639
- BDBM50147620
- AKOS027423696
- CCG-269672
- I-BRD9, >=98% (HPLC)
- SB19813
- NCGC00387308-01
- AC-36030
- AS-16366
- BP-25356
- DA-74385
- HY-18975
- SY347020
- S7835
- T6859
- C73296
- BRD-K04972057-001-01-1
Look up I-BRD9 in the interactive SynDRA portal →